Halozyme to Participate in the 2022 Wells Fargo Healthcare Conference

SAN DIEGO, Sept. 1, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the 2022 Wells Fargo Healthcare Conference being held in…

Click here to view original post